CLCN5
CLCN5 is a gene that encodes the protein chloride channel 5, which is a member of the CLC family of chloride channels and transporters. This protein is primarily expressed in the kidney and plays a crucial role in the reabsorption of chloride ions in the proximal tubules.
Function[edit | edit source]
The CLCN5 protein is involved in the regulation of chloride ion transport across cell membranes. It functions as an electrogenic antiporter, exchanging chloride ions for protons. This activity is essential for maintaining the proper ionic balance and pH within the kidney cells, which is critical for the reabsorption of various solutes and water.
Clinical Significance[edit | edit source]
Mutations in the CLCN5 gene are associated with Dent's disease, a rare X-linked recessive disorder characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis, and progressive renal failure. Patients with Dent's disease often present with symptoms such as kidney stones, bone demineralization, and renal tubular acidosis.
Pathophysiology[edit | edit source]
The mutations in CLCN5 disrupt the normal function of the chloride channel, leading to impaired reabsorption of filtered proteins and other solutes in the proximal tubules. This results in the characteristic features of Dent's disease, including proteinuria and hypercalciuria. The accumulation of calcium in the kidneys can lead to nephrocalcinosis and eventually to chronic kidney disease.
Diagnosis[edit | edit source]
The diagnosis of Dent's disease is typically based on clinical features, family history, and genetic testing to identify mutations in the CLCN5 gene. Urinalysis may reveal low molecular weight proteinuria, and imaging studies can detect nephrocalcinosis.
Treatment[edit | edit source]
There is currently no cure for Dent's disease, and treatment is primarily supportive. Management strategies include maintaining adequate hydration, using thiazide diuretics to reduce hypercalciuria, and monitoring and treating complications such as kidney stones and bone demineralization.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD